Kim WR. Survival Benefits of Direct-Acting Antiviral Therapy in Patients with Decompensated Hepatitis C Cirrhosis. PS-151.
Associatie community-acquired fluorochinolonresistente ‘E. coli’ en gebruik van antibiotica in de omgeving
jun 2019 | Antibioticaresistentie